Trial Profile
Efficacy of mepolizumab in steroid-dependent eosinophilic asthma: A retrosective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2018
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 05 Jul 2018 New trial record
- 23 May 2018 Results presented at the 114th International Conference of the American Thoracic Society